Termination of the Fast-Track for COVID-19-Related Appeals Pilot Program
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law ends the fast-track appeals process for COVID-19-related patent applications. Effective from April 16, 2026, the program will no longer accept petitions, allowing the USPTO to reallocate resources to other priorities. Businesses in the healthcare and pharmaceutical sectors need to be aware of the changes to appeals procedures and adjust their strategies accordingly.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Ends the fast-track process for COVID-19-related patent appeals
- Petitions filed after April 16, 2026, will not be accepted
- USPTO reallocates resources to other priorities
Obligations
What this law requires
Businesses in the healthcare and pharmaceutical sectors must adjust their strategies for appeals processes related to COVID-19 patents due to the termination of the Fast-Track for COVID-19-Related Appeals Pilot Program.
Any petitions for the Fast-Track for COVID-19-Related Appeals Pilot Program filed after midnight ET on April 16, 2026, will not be granted.
Applicants should not submit stored copies of form PTO/SB/454 after April 16, 2026.
The USPTO will continue to process petitions for the Fast-Track for COVID-19-Related Appeals Pilot Program filed by midnight ET on April 16, 2026.